The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
 
Sylvie Lorenzen
Consulting or Advisory Role - Lilly; Merck; Roche; Sanofi
 
Jorge Riera Knorrenschild
Consulting or Advisory Role - Pierre Fabre; Roche/Genentech
Travel, Accommodations, Expenses - MOLOGEN
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Honoraria - Celgene; MSD
Consulting or Advisory Role - Baxalta/Shire; BMS Brazil
 
Susanna Hegewisch-Becker
No Relationships to Disclose
 
Jörg Seraphin
No Relationships to Disclose
 
Peter C. Thuss-Patience
No Relationships to Disclose
 
Hans-Georg Kopp
No Relationships to Disclose
 
Tobias Nicolaas Dechow
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Delcath Systems; Lilly; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Delcath Systems; Lilly; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Kim Barbara Luley
No Relationships to Disclose
 
Daniel Pink
No Relationships to Disclose
 
Michael Stahl
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Holger Frithjof Hebart
No Relationships to Disclose
 
Jens T. Siveke
Consulting or Advisory Role - Baxalta; Celgene; Lilly; Merrimack
Research Funding - BMS Brazil; Celgene; Novartis
Travel, Accommodations, Expenses - Celgene; Roche
 
Matthias Egger
No Relationships to Disclose
 
Nils Homann
Consulting or Advisory Role - Amgen; Celgene; Lilly; Roche; Sanofi
 
Stephan Probst
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Roche; SERVIER
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma